CDNA

Caredx Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↑ 8/10
  • Value↓ 1/10
Caredx sales and earnings growth
CDNA Growth
Good
  • Revenue Y/Y↑ 28.96%
  • EPS Y/Y↓ -113.45%
  • FCF Y/Y↑ 221.84%
Caredx gross and profit margin trends
CDNA Profitability
Neutral
  • Gross margin ↑ 68.90%
  • EPS margin↓ -2.00%
  • ROIC 5Y↓ -23.34%
Caredx net debt vs free cash flow
CDNA Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -2.0

Caredx stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Diagnostics & Research stocks